181 related articles for article (PubMed ID: 8798161)
1. Measurement and calculation of heterogeneity correction factors for an Ir-192 high dose-rate brachytherapy source behind tungsten alloy and steel shields.
Kirov AS; Williamson JF; Meigooni AS; Zhu Y
Med Phys; 1996 Jun; 23(6):911-9. PubMed ID: 8798161
[TBL] [Abstract][Full Text] [Related]
2. TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy.
Kirov As; Williamson JF; Meigooni AS; Zhu Y
Phys Med Biol; 1995 Dec; 40(12):2015-36. PubMed ID: 8719942
[TBL] [Abstract][Full Text] [Related]
3. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
4. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
Williamson JF; Perera H; Li Z; Lutz WR
Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
[TBL] [Abstract][Full Text] [Related]
5. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
[TBL] [Abstract][Full Text] [Related]
6. Dose distributions produced by a shielded vaginal cylinder using a high-activity iridium-192 source.
Waterman FM; Holcomb DE
Med Phys; 1994 Jan; 21(1):101-6. PubMed ID: 8164574
[TBL] [Abstract][Full Text] [Related]
7. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
8. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
[TBL] [Abstract][Full Text] [Related]
10. Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy.
Valicenti RK; Kirov AS; Meigooni AS; Mishra V; Das RK; Williamson JF
Med Phys; 1995 Jun; 22(6):821-9. PubMed ID: 7565373
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source.
Karaiskos P; Angelopoulos A; Sakelliou L; Sandilos P; Antypas C; Vlachos L; Koutsouveli E
Med Phys; 1998 Oct; 25(10):1975-84. PubMed ID: 9800706
[TBL] [Abstract][Full Text] [Related]
12. Experimental and Monte Carlo dosimetry of the Henschke applicator for high dose-rate 192Ir remote afterloading.
Watanabe Y; Roy J; Harrington PJ; Anderson LL
Med Phys; 1998 May; 25(5):736-45. PubMed ID: 9608485
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources.
Nath R; Meigooni AS; Meli JA
Med Phys; 1990; 17(6):1032-40. PubMed ID: 2280732
[TBL] [Abstract][Full Text] [Related]
14. Dose calculation in brachytherapy for a 192Ir source using a primary and scatter dose separation technique.
Russell KR; Ahnesjö A
Phys Med Biol; 1996 Jun; 41(6):1007-24. PubMed ID: 8794481
[TBL] [Abstract][Full Text] [Related]
15. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
16. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
Nath R; Meigooni AS; Muench P; Melillo A
Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
[TBL] [Abstract][Full Text] [Related]
17. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
18. Determination of the tissue attenuation factor along two major axes of a high dose rate (HDR) 192Ir source.
Cho SH; Muller-Runkel R; Hanson WF
Med Phys; 1999 Aug; 26(8):1492-7. PubMed ID: 10501048
[TBL] [Abstract][Full Text] [Related]
19. Design and dosimetric characteristics of a high dose rate remotely afterloaded endocavitary applicator system.
Meigooni AS; Zhu Y; Williamson JF; Myerson RJ; Teague S; Löffler E; Nussbaum GH; Klein EE; Kodner IJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1153-63. PubMed ID: 8600101
[TBL] [Abstract][Full Text] [Related]
20. Dynamic modulated brachytherapy (DMBT) for rectal cancer.
Webster MJ; Devic S; Vuong T; Yup Han D; Park JC; Scanderbeg D; Lawson J; Song B; Tyler Watkins W; Pawlicki T; Song WY
Med Phys; 2013 Jan; 40(1):011718. PubMed ID: 23298088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
